ClinicalTrials.gov
ClinicalTrials.gov Menu

ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer (ARMOR1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00959959
Recruitment Status : Completed
First Posted : August 17, 2009
Last Update Posted : January 9, 2014
Sponsor:
Information provided by (Responsible Party):
Novus Therapeutics, Inc

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2011
  Actual Study Completion Date : August 2012